Membership Benefits

CTA provides a range of benefits to our network members. We are committed to supporting and strengthening the capacity and capability of our members via our key service areas, including:

  • Attracting and advocating for clinical trials to be hosted in Australia, specifically within member organisations.
  • Developing strategic partnerships within the clinical trials sector to promote and capitalise on member capabilities
  • Access to grant writing and management support services
  • Centralised feasibility evaluation to facilitate the efficient and timely review of new clinical trials
  • Coordination and hosting of quarterly meetings for 11 stream-based Tumour Groups
  • Access to clinical trial start-up and ongoing trial administration of ethics and governance activities
  • Financial administration of trial activity

CTA Tumour Streams

In 2004, CTA established a range of tumour groups across key tumour types, including; Brain, Breast, Gastro-intestinal, Gynaecology, Haematological Malignancies, Lung, Melanoma, Phase I and Uro-oncology studies. This has since expanded to include Head and Neck as of January 2019.

Tumour Stream Tumour Stream Chair
Brain Professor Hui Gan
Breast Dr Belinda Yeo
Gastro-intestinal Dr Margaret Lee
Gynaecology Associate Professor Sumitra Ananda
Haematology (Lymphoma/Myeloma) Professor Michael Dickinson
Haematology (Myeloid/AML) Dr Chun Fong
Head and Neck Professor Danny Rischin
Lung Dr Muhammad Alamgeer
Melanoma Dr George Au-Yeung
Phase I/Early Drug Development Associate Professor Ben Tran
Uro-Oncology Dr Mark Voskoboynik

Contact Us to discuss becoming part of the CTA  Member Network